Jon Snodgres - 16 Feb 2023 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
16 Feb 2023
Net transactions value
-$1,129,400
Form type
4
Filing time
17 Feb 2023, 15:56:31 UTC
Previous filing
11 Oct 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale $1,129,400 -5,647 -16% $200.00 29,325 16 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 06, 2022.